Genes Market, Global Outlook and Forecast
2022-2028 Market
CRISPR & Cas Genes Market, Global Outlook and Forecast 2022-2028 Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
CRISPR & Cas Genes Market, Global Outlook and Forecast 2022-2028 Market Size and Growth
The CRISPR & Cas Genes Market is expected to experience significant growth from 2022 to 2028 due to increasing investments in gene editing technologies and rising prevalence of genetic disorders. The global market size is projected to reach $5.3 billion by 2028, driven by advancements in CRISPR technology and applications in agriculture, healthcare, and biotechnology sectors.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ CRISPR Therapeutics
◍ AstraZeneca
◍ Addgene
◍ Caribou Biosciences, Inc.
◍ Cellectis
◍ Editas Medicine, Inc.
◍ Egenesis
◍ F. Hoffmann-La Roche Ltd.
◍ Horizon Discovery Group Plc
◍ Genscrip
◍ Danaher Corporation
◍ Intellia Therapeutics, Inc.
◍ Lonza
◍ Merck KGaA
◍ New England BioLabs
◍ Takara Bio, Inc.
◍ Synthego
◍ Mammoth Biosciences
The global CRISPR & Cas Genes Market is highly competitive with key players such as CRISPR Therapeutics, AstraZeneca, and Editas Medicine leading the market. These companies utilize CRISPR technology for gene editing to develop novel therapeutics and solutions for various applications in biotechnology, healthcare, and agriculture industries.
Market Segmentation
By Application
◍ Biotechnology and Pharmaceutical Companies
◍ Academics and Government Research Institutes
◍ Contract Research Organizations (CROs)
By Product
◍ Vector-based Cas ◍ DNA-free Cas ◍ Cell Line Engineering
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
